Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 494

1.

Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: A systematic review and meta-analysis.

Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K.

Reprod Toxicol. 2016 Dec;66:31-43. doi: 10.1016/j.reprotox.2016.09.013. Epub 2016 Sep 22.

PMID:
27667009
2.

Duloxetine prevents the effects of prenatal stress on depressive-like and anxiety-like behavior and hippocampal expression of pro-inflammatory cytokines in adult male offspring rats.

Zhang X, Wang Q, Wang Y, Hu J, Jiang H, Cheng W, Ma Y, Liu M, Sun A, Zhang X, Li X.

Int J Dev Neurosci. 2016 Dec;55:41-48. doi: 10.1016/j.ijdevneu.2016.09.005. Epub 2016 Sep 13.

PMID:
27637928
3.

Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study.

Grzeskowiak LE, McBain R, Dekker GA, Clifton VL.

BJOG. 2016 Nov;123(12):1929-1936. doi: 10.1111/1471-0528.13612. Epub 2015 Sep 15.

PMID:
26374444
4.

Prenatal antidepressant exposure and child behavioural outcomes at 7 years of age: a study within the Danish National Birth Cohort.

Grzeskowiak LE, Morrison JL, Henriksen TB, Bech BH, Obel C, Olsen J, Pedersen LH.

BJOG. 2016 Nov;123(12):1919-1928. doi: 10.1111/1471-0528.13611. Epub 2015 Sep 15.

PMID:
26374344
5.

Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review.

Viuff AC, Pedersen LH, Kyng K, Staunstrup NH, Børglum A, Henriksen TB.

Clin Epigenetics. 2016 Sep 7;8(1):94. doi: 10.1186/s13148-016-0262-x. eCollection 2016 Sep 7. Review.

6.

Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats.

Sprowles JL, Hufgard JR, Gutierrez A, Bailey RA, Jablonski SA, Williams MT, Vorhees CV.

Int J Dev Neurosci. 2016 Nov;54:39-52. doi: 10.1016/j.ijdevneu.2016.08.007. Epub 2016 Aug 31.

PMID:
27591973
7.

[Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Bergemann N, Paulus WE.

Nervenarzt. 2016 Sep;87(9):955-66. doi: 10.1007/s00115-016-0194-x. Review. German.

PMID:
27573672
8.

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

Daud AN, Bergman JE, Kerstjens-Frederikse WS, Groen H, Wilffert B.

Int J Mol Sci. 2016 Aug 13;17(8). pii: E1333. doi: 10.3390/ijms17081333. Review.

9.

Serotonin and poor neonatal adaptation after antidepressant exposure in utero.

Kieviet N, van Keulen V, van de Ven PM, Dolman KM, Deckers M, Honig A.

Acta Neuropsychiatr. 2017 Feb;29(1):43-53. doi: 10.1017/neu.2016.30. Epub 2016 Jul 8.

PMID:
27387606
10.

Does fish oil or folic acid prevent vascular changes in female progeny caused by maternal exposure to fluoxetine?

Higashi CM, Matsumoto AK, Gameiro JG, Moura KF, Higachi L, Oliveira LC, Barbosa DS, Moreira EG, Ceravolo GS.

Life Sci. 2016 May 1;152:165-70. doi: 10.1016/j.lfs.2016.03.042. Epub 2016 Mar 26.

PMID:
27021785
11.

Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.

Molenaar NM, Brouwer ME, Bockting CL, Bonsel GJ, van der Veere CN, Torij HW, Hoogendijk WJ, Duvekot JJ, Burger H, Lambregtse-van den Berg MP.

BMC Psychiatry. 2016 Mar 18;16:72. doi: 10.1186/s12888-016-0752-6.

12.

Neonatal SSRI exposure improves mitochondrial function and antioxidant defense in rat heart.

Braz GR, Freitas CM, Nascimento L, Pedroza AA, da Silva AI, Lagranha C.

Appl Physiol Nutr Metab. 2016 Apr;41(4):362-9. doi: 10.1139/apnm-2015-0494. Epub 2015 Nov 24.

PMID:
26939042
13.

Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.

Hermansen TK, Røysamb E, Augusti EM, Melinder A.

Psychopharmacology (Berl). 2016 Apr;233(8):1523-35. doi: 10.1007/s00213-016-4248-3. Epub 2016 Feb 29.

PMID:
26924747
14.

Effects of maternal stress and perinatal fluoxetine exposure on behavioral outcomes of adult male offspring.

Kiryanova V, Meunier SJ, Vecchiarelli HA, Hill MN, Dyck RH.

Neuroscience. 2016 Apr 21;320:281-96. doi: 10.1016/j.neuroscience.2016.01.064. Epub 2016 Feb 9.

PMID:
26872999
15.

Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring.

Boulle F, Pawluski JL, Homberg JR, Machiels B, Kroeze Y, Kumar N, Steinbusch HW, Kenis G, van den Hove DL.

Horm Behav. 2016 Apr;80:47-57. doi: 10.1016/j.yhbeh.2016.01.017. Epub 2016 Feb 1.

PMID:
26844865
16.

Antidepressants in pregnancy and autism.

[No authors listed]

Arch Dis Child. 2016 Mar;101(3):240. doi: 10.1136/archdischild-2016-310462. Epub 2016 Jan 19. No abstract available.

PMID:
26787608
17.

Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.

Velasquez JC, Goeden N, Herod SM, Bonnin A.

ACS Chem Neurosci. 2016 Mar 16;7(3):327-38. doi: 10.1021/acschemneuro.5b00287. Epub 2016 Jan 30.

PMID:
26765210
18.

Absence of evidence for increase in risk for autism or attention-deficit hyperactivity disorder following antidepressant exposure during pregnancy: a replication study.

Castro VM, Kong SW, Clements CC, Brady R, Kaimal AJ, Doyle AE, Robinson EB, Churchill SE, Kohane IS, Perlis RH.

Transl Psychiatry. 2016 Jan 5;6:e708. doi: 10.1038/tp.2015.190.

19.

Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.

Boukhris T, Sheehy O, Mottron L, Bérard A.

JAMA Pediatr. 2016 Feb;170(2):117-24. doi: 10.1001/jamapediatrics.2015.3356.

PMID:
26660917
20.

Assessing Risk of Autism Spectrum Disorder in Children After Antidepressant Use During Pregnancy.

King BH.

JAMA Pediatr. 2016 Feb;170(2):111-2. doi: 10.1001/jamapediatrics.2015.3493. No abstract available.

PMID:
26660503

Supplemental Content

Loading ...
Support Center